Han-Soo Keyoung
Director/Board Member bei HUGEL, INC.
Profil
Dr. Han-Soo Keyoung is on the Board of Directors at Hugel, Inc. and I-Mab Bio-tech (Tianjin) Co. Ltd.
Dr. Keyoung was previously employed as a Co-Chief Executive Officer & Director by Genexine, Inc. He received his doctorate degree from Cornell University.
Aktive Positionen von Han-Soo Keyoung
Unternehmen | Position | Beginn |
---|---|---|
HUGEL, INC. | Director/Board Member | 01.04.2022 |
I-Mab Bio-tech (Tianjin) Co. Ltd.
I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Director/Board Member | - |
Ehemalige bekannte Positionen von Han-Soo Keyoung
Unternehmen | Position | Ende |
---|---|---|
GENEXINE, INC. | Chief Executive Officer | - |
Ausbildung von Han-Soo Keyoung
Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GENEXINE, INC. | Health Technology |
HUGEL, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
I-Mab Bio-tech (Tianjin) Co. Ltd.
I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Health Technology |